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Abstract Stimulation of cells by epidermal growth factor in- 
duces a rapid polymerisation of actin in the cortical skeleton. 
Activation of the EGF-receptor leads to autophosphorylation a d 
to phosphorylation of specific intraceHular substrates. Here we 
show that actin is phosphorylated in vitro and in vivo upon EGF 
stimulation. Two-dimensional phospho-amino acid analysis hows 
that phosphorylation occurs on serine, not on tyrosine residues. 
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I. Introduction 
The cytoskeleton, and especially the actin microfilament sys- 
tem, plays an important role in growth factor-induced signal 
transduction. For example, EGF-receptor kinase activation 
leads to the phosphorylation f various cytoskeleton associated 
proteins [1 6]. Key enzymes in the EGF signal transduction 
cascade, like phosphatidylinositol kinase, phosphatidylinositol- 
4-phosphate kinase, diacylglycerol kinase and phospholipase C 
are associated with the cytoskeleton [7]. In addition it has been 
demonstrated that stimulation of cells with EGF or other li- 
gands affects actin organisation. Using immunofluorescence 
microscopy and confocal laser scanning microscopy it has been 
shown that EGF not only causes changes in the actin distribu- 
tion but also induces a significant increase in actin polymerisa- 
tion at the apical membrane-skeleton [8,9]. Furthermore it has 
been shown that immunoprecipitation of the cytoskeleton-as- 
sociated EGF-receptor resulted in co-immunoprecipitation of 
actin [8], while selective xtraction of cytoskeletons revealed an 
interaction between EGF-receptor and actin filaments [10]. 
Using highly purified components it has been demonstrated 
that the EGF-receptor can bind directly to actin via its cyto- 
plasmic domain with no other proteins involved [11]. Other 
growth factor receptors uch as NGF-receptor [12,13] and 
PDGF-receptor [14] are also associated with the cytoskeleton. 
As described above, a number of actin binding proteins, like 
fodrin, spectrin, tubulin and ezrin, have been demonstrated to 
become phosphorylated upon activation of cells by growth 
factors [1 6]. Of particular interest, however, is the observation 
that actin itself may be phosphorylated. Previously it has been 
shown that PKC can phosphorylate actin, phosphorylating G-
actin more efficiently than F-actin, but these studies were car- 
ried out exclusively in vitro. This phosphorylated actin was 
found to be more efficiently incorporated into F-actin than 
unphosphorylated actin. In contrast, phosphorylation f actin 
by PKA was found to polymerise less well than the 
phosphorylated form [15]. The Physarum polycephalum actin- 
fragmin complex is phosphorylated on threonine residues of 
actin by a monomeric 80 kDa protein and casein kinase I. The 
actin phosphorylation-dephosphorylation mechanism is sug- 
gested to regulate the organisation of the microfilament system 
in this organism [16]. In Dictyostelium cells tyrosine phospho- 
rylation of actin was found to increase when oxidative phos- 
phorylation was inhibited by 2,4-dinitrophenol [17]. It has been 
suggested that in these cells the phosphorylation f actin influ- 
ences the equilibrium between G- and F-actin or that the phos- 
phorylation of actin influences its association with other pro- 
teins. Starved Dictyostelium cells that return to growth medium 
show an increase in the amount of phosphorylated actin in 
time. Howard and coworkers have shown that changes in tyro- 
sine phosphorylation of actin correlates with changes in cell 
shape of Dictyostelium cells and therefore it may play a role in 
actin polymerisation-depolymerisation [18]. Tyrosine phos- 
phorylation of actin has also been found in an in vitro kinase 
assay with partially purified insulin receptor [19]. 
Since we have recently demonstrated that the EGF-receptor 
is an actin binding protein, it was of interest to establish 
whether actin itself is phosphorylated upon activation of EGF- 
receptor tyrosine kinase activity. We demonstrate hat indeed 
activation of the EGF-receptor tyrosine kinase results in the 
phosphorylation of actin in vivo and in vitro. However, the 
actin appears to be phosphorylated on serine residues rather 
than on tyrosine residues, demonstrating that actin itself is not 
a direct substrate of the EGF-receptor, but is a target of down- 
stream kinase activities. 
2. Materials and methods 
2.1. Tissue culture 
HER14 (NIH3T3 cells transfected with EGF-recptor cDNA, a gift 
from Dr. J. Schlessinger) fibroblasts and A431 cells were cultured in 
Dulbecco's modified Eagle's medium (DMEM) (Gibco, Paisley, UK) 
supplemented with 7.5% w/v fetal calf serum (FCS) (Gibco, Paisley, 
UK). 
*Corresponding author. Fax: (31) (30) 513 655. 
Abbreviations." ATE adenosine triphosphate; DMEM, Dulbecco, mod- 
ified Eagle's medium; EDTA, ethylene diamide tetra acetic acid; EGF, 
epidermal growth factor; FCS, fetal calf serum; NGF, nerve growth 
factor; PDGF, platelet-derived growth factor; PKA, protein kinase A; 
PKC, protein kinase C; PMSF, phenylmethylsulfonyl fluoride; SDS, 
sodium dodecyl sulphate; SDS-PAGE, sodium dodeeyl sulphate- 
polyacrylamide g lelectroforesis; TCA, trichloroacetic a id; TLC, thin 
layer chromatography. 
2.2. Membrane preparations 
Plasma membranes were prepared according to the method escribed 
by Thom et al. [20] with minor changes. Instead of using large amount 
of cells, the preparations were performed from 5-10 162-cm 2 dishes. No 
filtration through nylon gauze was performed. The plasma-membrane 
rich pellet was resuspended in phosphate buffered saline (PBS) with 
20% glycerol and when required stored at -20°C. 
2.3. 3:P-labeling of intact HER14 cells 
HER14 cells were grown on 75-cm 2dishes, serum starved (DMEM, 
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0% FCS) overnight and incubated in 5 ml phosphate-free DMEM 
containing 4 mCi [32Pl]Orthophosphate (Amersham International, UK) 
at 37°C for 4 h. Subsequently, cells were stimulated with EGF (50 
ng/ml) for 10 min and actin was immunoprecipitated from the cells. 
2.4. lmmunoprecipitation of actin and EGF-receptor 
Actin and EGF-receptor were immunoprecipitated from whole cell 
lysates or membrane preparations. Cells or membrane preparations 
were lysed in RIPA buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCI, 
0.5% Triton, 0.1% SDS, 1 mM EDTA, 1 mM PMSF, 1 mM Benzamid- 
ine, 100 mM NaF, 1 mM Na3VO4) at 4°C for 10 min and centrifuged 
for 5 min at 12,000 x g in an Eppendorf centrifuge. The supernatants 
were incubated with a 1 : 1 suspension of protein-A-Sepharose for 1 h 
at 4°C and centrifuged. The supernatants were either incubated with 
1/lg of anti-actin antibody (ICN Biomedicals, USA) or with 1/zg of 
anti-EGF-receptor antibody (Santa Cruz Biotechnology, Santa Cruz) 
for 3 h at 4°C. Subsequently protein-A-Sepharose was added and after 
a further incubation overnight he immunoprecipitates were washed 
three times, once with RIPA buffer, once with 0.5 M NaC1, 20 mM 
Tris-HC1 pH 7.4, 1% Triton, 1 mM PMFS, 1 mM Benzamidine, lmM 
Na3VO4, and finally with 0.15 M NaCI, 20 mM Tris-HC1 pH 7.4, 1% 
Triton, 1 mM PMFS, 1 mM Benzamidine, 1 mM Na3VO4. The beads 
were boiled in 20/11 Laemmli sample buffer for 5 rain and samples were 
separated by 10% SDS-PAGE. 
2.5. Phosphoamh~o acid analysis 
Phosphorylated actin bands were excised from stained and dried gels, 
allowed to swell in 500 ~tl 0.05 M ammonium bicarbonate for 5 rain. 
The gel piece was homogenised and another 500 HI 0.05 M ammonium 
bicarbonate was added together with 50 ,ul fl-mercaptoethanol and 
10/,~1 0% SDS. Samples were boiled for 10 min and rotated overnight 
at 37°C. Protein was precipitated with TCA and washed with 100% 
ethanol. Pellet was dissolved in 50¢tl 6 N HCI and hydrolysed at 110°C 
for 1 h, the pellet was resuspended in water and lyophilised overnight. 
Samples were resuspended in buffer pH 1.9 (2.2% formic acid, 7.8% 
acetic acid) containing phosphoserine, phosphothreonine and 
phosphotyrosine as markers. The samples were spotted on a TLC plate 
and subjected to two-dimensional high voltage thin layer chromatogra- 
phy. The first dimension was run at 1.5 kV with buffer pH 1.9. The 
second dimension was run at 1.3 kV with buffer pH 3.5 (5% glacial 
acetic acid, 0.5% pyridine). Markers were visualised by ninhydrin and 
radioactivity by autoradiography. 
2.6. Kinase assay 
Membranes (30/.tg) were incubated for 10 min at room temperature 
with 100 ng EGF in a volume of 30/11. The reaction was started by 
adding 10 ¢tl 1.5 M ammonium sulphate and 20 ,ul reaction buffer 
(60 mM HEPES pH 7.4, 15 mM MgC12, 6 mM MnCI2, 60 mM Na3VO4, 
and either 10 ¢tCi [?-32p]ATP (Amersham International, UK) or 60,uM 
ATP (Boehringer Mannheim, Mannheim). The mixture was incubated 
for 20 min at 37°C, after which an immunoprecipitation of actin was 
performed. For assays carried out in the presence of protein kinase 
inhibitors, EGF was added together with inhibitors at concentrations 
varying from 10-500/~M. 
3. Results 
3.1. In vitro phosphorylation o f  actin 
It was demonstrated previously that the EGF-receptor is an 
actin binding protein [11] and since actin can be phosphorylated 
in vitro by several protein k inases [15-19], we have studied the 
possibility that actin is phosphorylated by the EGF-receptor  
tyrosine kinase. Therefore in vitro kinase assays were per- 
formed using membranes i olated from Her l4  and A431 cells 
as described in section 2. EGF  was added to the membranes 
for 10 minutes at room temperature and a kinase assay was 
performed as described in section 2. Actin was then im- 
munoprecipitated from the membranes and samples were sepa- 
rated on a 10% SDS gel, which was subsequently subjected to 
autoradiography. As shown in Fig. 1A, addit ion of EGF  to 
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Fig. 1. EGF stimulation ofactin phosphorylation in vitro. Thom mem- 
branes prepared from A431 or HER14 cells were either left untreated 
(lanes 1 and 3), or stimulated with 200 ng EGF (lanes 2 and 4) for 
10 rain at room temperature b fore performing an in vitro kinase assay. 
Actin and the EGF-receptor were immunoprecipitated as escribed in 
section 2, and separated by 10% SDS-PAGE. Arrows indicate bands 
corresponding to phosphorylated EGF-receptor (A) and actin (B). 
membranes i olated from A431 cells resulted in an increase in 
the phosphorylat ion state of the EGF-receptor (lane 1 without 
EGF, lane 2 with EGF). A similar increase was observed in the 
phosphorylat ion state of the EGF-receptor upon addition of 
EGF  to membranes i olated from HERI4  cells (compare lane 
3 and 4). Fig. 1B shows phosphorylat ion of actin immunopre- 
cipitated from the same membranes as the EGF-receptor. 
Again a clear phosphorylat ion of actin after EGF  stimulation 
is detected (lane 2 and 4) in both cell types as compared to the 
unstimulated membranes (lanes 1 and 3). These data demon- 
strate clearly that in vitro actin becomes phosphorylated upon 
EGF stimulation. No actin was added to these membranes, 
indicating that the actin phosphorylated in this manner  is part 
of the membrane skeleton. 
Since the EGF-receptor  is an actin binding protein it is 
tempting to speculate that actin is a direct substrate of the 
EGF-receptor. To establish the role of the EGF-receptor tyro- 
sine kinase in more detail, a kinase assay was performed in the 
presence of tyrphostin-47, a tyrosine kinase inhibitor specific 
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Fig. 2. Actin phosphorylation in vitro is inhibited by the tyrosine kinase 
inhibitor tyrphostin-47. Thorn membranes prepared from A431 or 
HERI4 cells were stimulated with 200 ng of EGF and increasing con- 
centrations of tyrphostin-47 (10, 50 and 200/2M) for 10 rain at room 
temperature before performing an in vitro kinase assay. Actin was 
immunoprecipitated which resulted in a co-immunoprecipitation of the 
EGF-receptor and the immunoprecipitates were seperated by 10% 
SDS-PAGE. Arrows indicate bands corresponding to phosphorylated 
EGF-receptor and actin. 
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for the EGF-receptor [21]. Membranes were treated with EGF 
and increasing concentrations of tyrphostin-47. Subsequently 
actin was immunoprecipitated as escribed in section 2. In Fig. 
2 both actin and the EGF-receptor are visible which is a result 
of a co-immunoprecipitation of the EGF-receptor with actin. 
As shown in Fig. 2 both the phosphorylation of the EGF- 
receptor and actin decreases by increasing concentrations of
tyrphostin-47 for both cell types. The decline in phosphoryla- 
tion in HER14 cells is more rapid than in A431 cells, which 
contain more EGF-receptors. These data indicate that actin 
phosphorylation i duced by EGF in vitro is directed by the 
EGF-receptor tyrosine kinase activity. Subsequently a Western 
blot was prepared of kinase assay samples prepared with cold 
ATE This Western blot was incubated with anti-phospho-tyro- 
sine antibody (UBI, Lake Placid USA). Fig. 3 shows the bands 
representing the EGF-receptor in A431 and HER14 cells upon 
EGF addition but no bands representing actin was detected. 
These findings demonstrate hat phosphorylation f actin upon 
EGF stimulation is, in fact, not on tyrosine residues, and there- 
fore in vitro actin appears not to be a substrate of the EGF- 
receptor itself, but from another kinase whose activity is regu- 
lated by EGF through the EGF-receptor. 
3.2. In vivo phosphorylation of  actin 
Phosphorylation ofactin in vivo was studied in HERI4 cells. 
HER14 cells were labelled with [32P]orthophosphate for 4 h, 
before stimulation with 50 ng/ml EGF for 10 rain. After im- 
munoprecipitation f actin, samples were separated on a 10% 
SDS gel (Fig. 4). Fig. 4A shows a band of phosphorylated actin 
in the stimulated cells (lane 2) but not in the control cells (lane 
1). The remaining three bands are seen in both the control cells 
and the stimulated cells. These are probably phosphoproteins 
binding to actin. Figure 4B shows the phosphorylation of the 
EGF receptor in stimulated (lane 4) and unstimulated (lane 3) 
cells, immunoprecipitated from the same cell lysates as a con- 
trol for the EGF receptor activity. In vivo actin becomes 
phosphorylated by stimulation of cells with 50 ng/ml EGF for 
10 min. To determine which amino acid residue is 
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Fig. 3. Anti-phosphotyrosine W stern analysis of EGF stimulated actin 
phosphorylation. Thom membranes prepared from A431 or HER14 
cells were used to phosphorylate actin in vitro as described above. Actin 
immunoprecipitates were separated by 10% SDS-PAGE, and trans- 
ferred to nitrocellulose. Blots were incubated with anti-phosphoty- 
rosine antibody (4G10, UBI, Lake Placid) and developed by enhanced 
chemiluminescence (Amersham International, UK) using standard pro- 
tocols. Arrows indicate position of the EGF-receptor and actin. 
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Fig. 4. In vivo actin phosphorylation upon EGF stimulation HERI4 
cells were starved O/N in DMEM-7.5% FCS and labelled for four hours 
with [32p]orthophosphate as d scribed in section 2. Both actin and the 
EGF-receptor were immunoprecipitated from the cells after 10 rain of 
stimulation with 50 ng/ml EGF and the proteins were separated by 10% 
SDS-PAGE. Arrows indicate phosphorylated actin (A) and EGF- 
receptor (B). 
phosphorylated, the excised band of phosphorylated actin was 
subjected to phospho-amino acid analysis. Fig. 5A shows a 
phospho-serine spot of hydrolysed actin while Fig. 5B shows 
a schematic representation f the position of the three phospho- 
amino acids. In vivo actin is phosphorylated on serine and not 
on tyrosine residues upon EGF stimulation, confirming that the 
phosphorylation of actin is not caused by the EGF-receptor, 
but by a serine/threonine kinase that becomes activated after 
EGF stimulation. 
4. D iscuss ion  
One of the results of stimulation of the EGF-receptor is 
phosphorylation of various cytoskeletal components. Actin, 
being a cytoskeletal protein and directly bound to the EGF- 
receptor is a good candidate for EGF directed phosphoryla- 
tion. Our results, however, demonstrate hat in vivo actin be- 
comes phosphorylated on serine and not on tyrosine residues 
upon EGF stimulation. In addition we found that membrane 
bound actin in vitro serves as substrate for a serine/threonine 
kinase stimulated after EGF addition. The identity of this 
serine/threonine kinase is not yet known. 
The actin found to be phosphorylated is only a very small 
percentage of total cell actin, and as demonstrated in the in 
vitro studies is present in the membrane preparations. This 
suggests that the phosphorylated actin is part of the membrane 
skeleton and may be present in membrane ruffles. Membrane 
ruffles appear after stimulation of cells by growth factors such 
as EGF [22,23]. These ruffles are thought to be a focus of signal 
transduction events, in that active receptors and tyrosine 
phosphorylated proteins are highly localised in the membrane 
ruffles. Various actin binding proteins like, ezrin, spectrin and 
calpactin II are also recruited to the ruffles and become 
phosphorylated onboth serine, threonine and tyrosine residues 
upon EGF treatment of cells [6,24]. Thus, another possible 
function of actin phosphorylation could be that actin phospho- 
rylation is used to create a specific binding site for other pro- 
teins. 
As previously described, evidence has been obtained that the 
phosphorylation of actin facilitates actin polymerisation [15]. 
As such it seems attractive to suggest hat the EGF-induced 
phosphorylation f actin is involved in the EGF-induced actin 
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Fig. 5. Phospho-amino acid analysis (PAA) of in vivo phosphorylated 
actin. Actin phosphorylated in vivo was excised from the gel, TCA 
precipitated and hydrolysed with HCI as described in section 2. 
Phosphorylated amino acids were separated in two dimensions on thin 
layer chromatography plates, and their position compared to migration 
of cold phospho-amino acid standards. (A) autoradiograph of actin 
phospho-amino acids after EGF stimulation. (B) schematic representa- 
tion of the migration pattern of cold phospho-amino acid standards. 
polymerisation [8]. Of interest in this respect is the fact that the 
EGF-induced actin polymerisation is restricted to the cortical 
cell area [9], and here we have demonstrated that actin phos- 
phorylation is due to a serine kinase present in the membrane 
fraction (Fig. 1). Thus the EGF-induced actin phosphorylation 
probably occurs at the same cell location as the actin polymer- 
isation, suggesting that these two processes may be linked to 
each other. There are several serine/threonine kinases that are 
activated upon EGF that bind to the membrane such as Raf  
[25], or casein kinase I [26], thus any of these could be a candi- 
date for delivering the kinase activity that phosphorylates actin. 
Currently work is underway, using specific inhibitors and im- 
munocomplex kinase assays to determine if any of these kinases 
can phosphorylate actin in vitro. 
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